In this webcam image provided by the U.S. Geological Survey, an eruption takes place on the summit of the Kilauea volcano in Hawaii, Wednesday, June 7, 2023. (U.S. Geological Survey via AP)
By Jennifer Sinco Kelleher and Mark Thiessen
Kilauea, one of the most active volcanoes in the world, began erupting on Wednesday after a three-month pause, displaying spectacular fountains of mesmerizing, glowing lava that's a safe distance from people and structures in a national park on the Big Island.
The U.S. Geological Survey's Hawaiian Volcano Observatory said in a statement that a glow was detected in webcam images from Kilauea’s summit early in the morning, indicating that an eruption was occurring within the Halemaumau crater in the summit caldera.
The images show fissures at the base of the crater generating lava flows on the crater floor's surface, the observatory said.
Before issuing the eruption notice, the observatory said increased earthquake activity and changes in the patterns of ground deformation at the summit started Tuesday night, indicating the movement of magma in the subsurface.
“We’re not seeing any signs of activity out on the rift zones right now,” said Mike Zoeller, a geologist with the observatory. “There’s no reason to expect this to transition into a rift eruption that would threaten any communities here on the island with lava flows or anything like that.”
All activity was within a closed area of Hawaii Volcanoes National Park.
“The lava this morning is all confined within ... the summit caldera. So plenty of room for it still to produce more without threatening any homes or infrastructure,” said park spokesperson Jessica Ferracane. “So that’s the way we like our eruptions here.”
She said park officials are bracing for crowds to arrive because visitors can see the eruption from many overlooks.
“Kilauea overlook was spectacular this morning," she said of the vast lava lake. “It was molten red lava. There’s several areas of pretty robust fountaining. It’s just really, really pretty.”
The lava lake, covering the crater floor over lava that remained from previous eruptions, measured at about 371 acres (150 hectares) at about 6 a.m., Zoeller said. It measured about 4,300 feet (1,300 meters) wide.
Word was getting out and parking lots were starting to fill up at the park, she said, adding that she expected long lines getting into the park by evening.
Since the park is open 24 hours a day, visitors can beat the crowds by visiting between 9 p.m. and sunrise, Ferracane said.
She reminded visitors to stay out of closed areas and remain on marked trails for safety reasons, including avoiding gases from the eruption.
Two small earthquakes jolted Janice Wei, who lives in nearby town of Volcano. As a volunteer photographer for the park, she was able to see fountains she estimated to be 150 feet (46 meters) high at around 4:30 a.m.
She said she saw about 15 fountains, which were dying down by mid-morning.
The volcano’s alert level was raised to warning status and the aviation color code went to red as scientists evaluate the eruption and associated hazards.
Kilauea, Hawaii's second-largest volcano, erupted from September 2021 until last December. For about two weeks in December, Hawaii’s biggest volcano, Mauna Loa, also was erupting on Hawaii’s Big Island.
This eruption is looking very similar, Zoeller said: “This eruption is following a very similar playbook to the last three that we’ve seen here since 2020.”
A 2018 Kilauea eruption destroyed more than 700 homes.
Before the major 2018 eruption, Kilauea had been erupting since 1983, and streams of lava occasionally covered farms and homes. During that time, the lava sometimes reached the ocean, causing dramatic interactions with the water.
Healthcare workforce management platform ShiftMed
recently announced a $45 million funding round.
The company's platform connects nurses and healthcare professionals to hospitals and other healthcare providers.
ShiftMed's new funding comes amid widespread labor shortages in the healthcare sector. The company's CEO Todd Walrath joins Cheddar News' Closing Bell to discuss.
Universities like UCLA, Yale, and Duke have announced they're implementing remote learning amid the COVID omicron variant surge, despite President Biden recommending that K-12 schools should continue in-person education. Jared C. Bass, senior director for Higher Education at American Progress, joined Cheddar to break down what institutions of higher education might be considering differently. "I think some universities are allowing periods of a bit of a respite to allow students to get testing and make sure when they do return back to campus that they're healthy," he noted.
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Dr. Rob Davidson, Executive Director of the Committee to Protect Health Care and an ER Physician in West Michigan, joins Cheddar News to break down the expectations of Pfizer's new COVID-19 treatment pill.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
